PFE

NYSE

PFIZER INC

Latest disclosureOctober 1, 2026

Insider score Why 55?: 55/ 100
Qualifying buys · 30d: $0

3 purchases · 2 sales

Price by TradingView

Insider transactions 49

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Sale disclosed

Jennifer B. Damico

SVP & Controller

Common Stock

Reported value: $83.26K
Reported price: $25.40 / share

Sale disclosed

Jennifer B. Damico

SVP & Controller

Common Stock

Reported value: $51.4K
Reported price: $25.70 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
SVP & Controller	Common StockSale	3,278$25.40 / share	$83.26K	Aug 5Filed Aug 6 · 1d later	SEC filing
SVP & Controller	Common StockSale	2,000$25.70 / share	$51.4K	Jun 9Filed Jun 10 · 1d later	SEC filing

Congress transactions 11

All Congress filings

Sale disclosedAmended report

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a sale for a spouse.

Carol Devine MillerReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: March 10, 2025

Sale disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a sale for the member.

Michael RulliReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 26, 2024

Full sale disclosedAmended report

Pfizer, Inc. Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: May 3, 2024

Full sale disclosed

Pfizer, Inc. Common Stock · Stock

The filing reports a full sale for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $50,001 – $100,000Reported range; exact amount not disclosed.
Trade date: March 24, 2026

Full sale disclosed

Pfizer, Inc. Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: June 8, 2026

Partial sale disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 13, 2026

Purchase disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 10, 2026

Sale disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a sale for the member.

James French HillReporting House member

Reported amount: $100,001 – $250,000Reported range; exact amount not disclosed.
Trade date: December 31, 2025

Purchase disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a purchase for the member.

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 17, 2025

Partial sale disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 19, 2025

Purchase disclosed

Pfizer, Inc. Common Stock (PFE) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 18, 2025

Why this buying score?

Qualifying common-equity purchase value

$1,828,244 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+13 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+11 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+6 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000078003
Latest public acceptance: Oct 1, 2026, 06:04 PM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

SVP & Controller

Common StockSale

3,278$25.40 / share

$83.26K

Aug 5Filed Aug 6 · 1d later

SEC filing

SVP & Controller

Common StockSale

2,000$25.70 / share

$51.4K

Jun 9Filed Jun 10 · 1d later

SEC filing

Why this buying score?

Qualifying common-equity purchase value

$1,828,244 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+13 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+11 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+6 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000078003
Latest public acceptance: Oct 1, 2026, 06:04 PM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.